We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

9 hedge funds and large institutions have $1.94M invested in PAVmed Inc. Series Z Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 99 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

6% less capital invested

Capital invested by funds: $2.06M → $1.94M (-$119K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PAVMZ Hedge Fund Activity: Q2 2021 in Review

9 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2021, worth a combined $1.94M — down 5.8% from $2.06M a quarter earlier.

Fund positioning in PAVMZ was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 4 trimmed.

The largest buyer was Warberg Asset Management, adding an estimated $354K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $1.1M sold.

  • 9 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $1.94M of PAVmed Inc. Series Z Warrant stock for Q2 2021, down 5.8% quarter-over-quarter.
  • 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q2 2021 was Warberg Asset Management, an estimated $354K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q2 2021 was Raymond James & Associates, an estimated $1.1M sold.

Based on aggregated 13F filings for Q2 2021.